These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36579370)

  • 1. The influence of viral protein R amino acid substitutions on clinical outcomes in people living with HIV: A systematic review.
    Asia LK; Jansen Van Vuren E; Williams ME
    Eur J Clin Invest; 2023 May; 53(5):e13943. PubMed ID: 36579370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.
    Dampier W; Antell GC; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; James T; Devlin KN; Giovannetti T; Libon DJ; Szep Z; Ehrlich GD; Wigdahl B; Krebs FC
    J Neurovirol; 2017 Feb; 23(1):113-124. PubMed ID: 27400931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot investigation of the association between HIV-1 Vpr amino acid sequence diversity and the tryptophan-kynurenine pathway as a potential mechanism for neurocognitive impairment.
    Asia LK; Van Vuren EJ; Lindeque Z; Williams ME
    Virol J; 2024 Feb; 21(1):47. PubMed ID: 38395987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variance in the HIV-1 founder virus Vpr affects its ability to induce cell cycle G₂arrest and cell apoptosis.
    Zhao JY; Ding JW; Mi ZY; Zhou JM; Wei T; Cen S
    Yi Chuan; 2015 May; 37(5):480-6. PubMed ID: 25998437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90.
    Tcherepanova I; Starr A; Lackford B; Adams MD; Routy JP; Boulassel MR; Calderhead D; Healey D; Nicolette C
    PLoS One; 2009 Jun; 4(6):e5853. PubMed ID: 19516896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The host-pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domains.
    Solbak SM; Wray V; Horvli O; Raae AJ; Flydal MI; Henklein P; Henklein P; Nimtz M; Schubert U; Fossen T
    BMC Struct Biol; 2011 Dec; 11():49. PubMed ID: 22185200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 Vpr polymorphisms associated with progressor and nonprogressor individuals alter Vpr-associated functions.
    Hadi K; Walker LA; Guha D; Murali R; Watkins SC; Tarwater P; Srinivasan A; Ayyavoo V
    J Gen Virol; 2014 Mar; 95(Pt 3):700-711. PubMed ID: 24300552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Vpr redirects host ubiquitination pathway.
    Arora S; Verma S; Banerjea AC
    J Virol; 2014 Aug; 88(16):9141-52. PubMed ID: 24899191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Subtype C Vpr Amino Acid Residue 45Y and Specific Conserved Fragments Are Associated with Neurocognitive Impairment and Markers of Viral Load.
    Ruhanya V; Jacobs GB; Paul RH; Joska JA; Seedat S; Nyandoro G; Glashoff RH; Engelbrecht S
    AIDS Res Hum Retroviruses; 2023 Apr; 39(4):166-175. PubMed ID: 36401355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence.
    Na H; Acharjee S; Jones G; Vivithanaporn P; Noorbakhsh F; McFarlane N; Maingat F; Ballanyi K; Pardo CA; Cohen EA; Power C
    Retrovirology; 2011 Jun; 8():44. PubMed ID: 21645334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.
    Venkatachari NJ; Walker LA; Tastan O; Le T; Dempsey TM; Li Y; Yanamala N; Srinivasan A; Klein-Seetharaman J; Montelaro RC; Ayyavoo V
    Virol J; 2010 Jun; 7():119. PubMed ID: 20529298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional conservation of HIV-1 Vpr and variability in a mother-child pair of long-term non-progressors.
    Zhao Y; Chen M; Wang B; Yang J; Elder RT; Song XQ; Yu M; Saksena NK
    Virus Res; 2002 Oct; 89(1):103-21. PubMed ID: 12367754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral protein R (Vpr)-induced neuroinflammation and its potential contribution to neuronal dysfunction: a scoping review.
    Williams ME; Williams AA; Naudé PJW
    BMC Infect Dis; 2023 Aug; 23(1):512. PubMed ID: 37545000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.
    González ME
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Vpr suppresses the cytomegalovirus promoter in a CRL4(DCAF1) E3 ligase independent manner.
    Liu X; Guo H; Wang H; Markham R; Wei W; Yu XF
    Biochem Biophys Res Commun; 2015 Apr; 459(2):214-219. PubMed ID: 25704090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Temporal Viromics of an Inducible HIV-1 Model Yields Insight to Global Host Targets and Phospho-Dynamics Associated with Protein Vpr.
    Lapek JD; Lewinski MK; Wozniak JM; Guatelli J; Gonzalez DJ
    Mol Cell Proteomics; 2017 Aug; 16(8):1447-1461. PubMed ID: 28606917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of two unique naturally occurring Vpr sequence polymorphisms associated with clinical parameters in HIV-1 chronic infection.
    Kamori D; Hasan Z; Ohashi J; Kawana-Tachikawa A; Gatanaga H; Oka S; Ueno T
    J Med Virol; 2017 Jan; 89(1):123-129. PubMed ID: 27328918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLX4-SLX1 Protein-independent Down-regulation of MUS81-EME1 Protein by HIV-1 Viral Protein R (Vpr).
    Zhou X; DeLucia M; Ahn J
    J Biol Chem; 2016 Aug; 291(33):16936-16947. PubMed ID: 27354282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.
    Barbosa JAF; Sparapani S; Boulais J; Lodge R; Cohen ÉA
    J Virol; 2021 Jul; 95(15):e0097120. PubMed ID: 34011540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the 15FRFG domain in HIV-1 Gag p6 essential for Vpr packaging into the virion.
    Zhu H; Jian H; Zhao LJ
    Retrovirology; 2004 Sep; 1():26. PubMed ID: 15363109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.